SCHEMBL6950951

SCHEMBL6950951

COc1cc2c(cc1N(C)[C@H]1CCCN[C@H]1c1ccccc1)C(C)(C(F)(F)F)OCC2O

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 19/20 0.48
CYP2D6 P10635 8/20 0.48
KCNH2 Q12809 1/20 0.37
HTR1A P08908 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HRH1 P35367 1/20 0.36
HTR2B P41595 1/20 0.36
SLC6A3 Q01959 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907938 0.85 TACR1 (0.65) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL6402148 0.85 TACR1 (0.65) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL6401334 0.85 TACR1 (0.65) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL4919798 0.84 TACR1 (0.66) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL6400810 0.84 TACR1 (0.66) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL4917686 0.84 TACR1 (0.66) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL8116125 0.83 TACR1 (0.65) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL6405907 0.83 TACR1 (0.65) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL6406212 0.83 TACR1 (0.65) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL7535194 0.81 TACR1 (0.46) TACR1CYP2D6KCNH2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178984-B1 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYL-AMINOMETHYLCHROMAN DERIVATIVES PFIZER PROD INC (US) 2003-03-19 EP claimed
US-6239147-B1 TO TREAT CNS, GASTROINTESTINAL AND OTHER DISORDERS. SUBSTANCE P ANTAGONISTS HAVING IMPROVED ACTIVITY AND FEWER SIDE EFFECTS, TREATMENT OF EMESIS INDUCED BY ANTINEOPLASTIC AGENTS, ISOCHROMAN RING PFIZER INC 2001-05-29 US claimed